PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX???'s New Drug Application

Stock Information for PolyPid Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PolyPid Ltd.

PolyPid Announces Participation in Upcoming Investor Conferences
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX??? Supporting NDA Submission
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
PolyPid's D-PLEX??? Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.